Results: 1-25 | 26-50 | 51-75 | 76-100 | >>

Table of contents of journal: *Drugs

Results: 1-25/214

Authors: May, SW Pollock, SH
Citation: Sw. May et Sh. Pollock, Selenium-based antihypertensives - Rationale and potential, DRUGS, 56(6), 1998, pp. 959-964

Authors: Alexander, JH Harrington, RA
Citation: Jh. Alexander et Ra. Harrington, Recent antiplatelet drug trials in the acute coronary syndromes - Clinicalinterpretation of PRISM, PRISM-PLUS, PARAGON A and PURSUIT, DRUGS, 56(6), 1998, pp. 965-976

Authors: Gonzalez-Amaro, R Diaz-Gonzalez, F Sanchez-Madrid, F
Citation: R. Gonzalez-amaro et al., Adhesion molecules in inflammatory diseases, DRUGS, 56(6), 1998, pp. 977-988

Authors: Wanstall, JC Jeffery, TK
Citation: Jc. Wanstall et Tk. Jeffery, Recognition and management of pulmonary hypertension, DRUGS, 56(6), 1998, pp. 989-1007

Authors: Davidson, RN
Citation: Rn. Davidson, Practical guide for the treatment of leishmaniasis, DRUGS, 56(6), 1998, pp. 1009-1018

Authors: Canal, P Chatelut, E Guichard, S
Citation: P. Canal et al., Practical treatment guide for dose individualisation in cancer chemotherapy, DRUGS, 56(6), 1998, pp. 1019-1038

Authors: McClellan, KJ Markham, A
Citation: Kj. Mcclellan et A. Markham, Telmisartan, DRUGS, 56(6), 1998, pp. 1039-1044

Authors: Sharpe, N
Citation: N. Sharpe, Telmisartan - A viewpoint, DRUGS, 56(6), 1998, pp. 1045-1046

Authors: Aronow, WS
Citation: Ws. Aronow, Telmisartan - A viewpoint, DRUGS, 56(6), 1998, pp. 1045-1045

Authors: Elliott, HL
Citation: Hl. Elliott, Telmisartan - A viewpoint, DRUGS, 56(6), 1998, pp. 1045-1045

Authors: Langtry, HD Balfour, JA
Citation: Hd. Langtry et Ja. Balfour, Azithromycin: a review of its use in paediatric infectious diseases (vol 56, pg 273, 1998), DRUGS, 56(6), 1998, pp. 1046-1046

Authors: Lamb, HM Wiseman, LR
Citation: Hm. Lamb et Lr. Wiseman, Pexiganan acetate, DRUGS, 56(6), 1998, pp. 1047-1052

Authors: Lipsky, BA
Citation: Ba. Lipsky, Pexiganan acetate - A viewpoint, DRUGS, 56(6), 1998, pp. 1053-1053

Authors: Wise, R
Citation: R. Wise, Pexiganan acetate - A viewpoint, DRUGS, 56(6), 1998, pp. 1053-1054

Authors: Adkins, JC Noble, S
Citation: Jc. Adkins et S. Noble, Efavirenz, DRUGS, 56(6), 1998, pp. 1055-1064

Authors: Conway, B
Citation: B. Conway, Efavirenz - A viewpoint, DRUGS, 56(6), 1998, pp. 1065-1066

Authors: Easterbrook, PJ
Citation: Pj. Easterbrook, Efavirenz - A viewpoint, DRUGS, 56(6), 1998, pp. 1065-1065

Authors: McClellan, KJ Goa, KL
Citation: Kj. Mcclellan et Kl. Goa, Tirofiban - A review of its use in acute coronary syndromes, DRUGS, 56(6), 1998, pp. 1067-1080

Authors: Markham, A Faulds, D
Citation: A. Markham et D. Faulds, Theophylline - A review of its potential steroid sparing effects in asthma, DRUGS, 56(6), 1998, pp. 1081-1091

Authors: Waghorn, SL Goa, KL
Citation: Sl. Waghorn et Kl. Goa, Zanamivir (vol 55, pg 721, 1998), DRUGS, 56(6), 1998, pp. 1091-1091

Authors: McNeely, W Goa, KL
Citation: W. Mcneely et Kl. Goa, Sibutramine - A review of its contribution to the management of obesity, DRUGS, 56(6), 1998, pp. 1093-1124

Authors: Lamb, HM Adkins, JC
Citation: Hm. Lamb et Jc. Adkins, Letrozole - A review of its use in postmenopausal women with advanced breast cancer, DRUGS, 56(6), 1998, pp. 1125-1140

Authors: ALLEN TM
Citation: Tm. Allen, LIPOSOMAL DRUG FORMULATIONS - RATIONALE FOR DEVELOPMENT AND WHAT WE CAN EXPECT FOR THE FUTURE, Drugs, 56(5), 1998, pp. 747-756

Authors: TAUB JW
Citation: Jw. Taub, FACTORS IN IMPROVED SURVIVAL FROM PEDIATRIC CANCER, Drugs, 56(5), 1998, pp. 757-765

Authors: GUERRA PG TALAJIC M ROY D DUBUC M THIBAULT B NATTEL S
Citation: Pg. Guerra et al., IS THERE A FUTURE FOR ANTIARRHYTHMIC DRUG-THERAPY, Drugs, 56(5), 1998, pp. 767-781
Risultati: 1-25 | 26-50 | 51-75 | 76-100 | >>